Literature DB >> 22284420

Metallothionein genes: no association with Crohn's disease in a New Zealand population.

Angharad R Morgan1, Alan G Fraser, Lynnette R Ferguson.   

Abstract

Metallothioneins (MTs) are excellent candidate genes for Inflammatory Bowel Disease (IBD) and have previously been shown to have altered expression in both animal and human studies of IBD. This is the first study to examine genetic variants within the MT genes and aims to determine whether such genetic variants have an important role in this disease. 28 tag SNPs in genes MT1 (subtypes A, B, E, F, G, H, M, X), MT2, MT3 and MT4 were selected for genotyping in a well-characterized New Zealand dataset consisting of 406 patients with Crohn's Disease and 638 controls. We did not find any evidence of association for MT genetic variation with CD. The lack of association indicates that genetic variants in the MT genes do not play a significant role in predisposing to CD in the New Zealand population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284420      PMCID: PMC3280932          DOI: 10.1186/1477-5751-11-8

Source DB:  PubMed          Journal:  J Negat Results Biomed        ISSN: 1477-5751


  19 in total

1.  Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes.

Authors:  I C Lawrance; C Fiocchi; S Chakravarti
Journal:  Hum Mol Genet       Date:  2001-03-01       Impact factor: 6.150

2.  Increased expression of metallothionein in inflammatory bowel disease.

Authors:  M Brüwer; K W Schmid; K A Metz; C F Krieglstein; N Senninger; G Schürmann
Journal:  Inflamm Res       Date:  2001-06       Impact factor: 4.575

3.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

4.  The immunohistochemical expression of metallothionein in inflammatory bowel disease. Correlation with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices.

Authors:  E Ioachim; M Michael; C Katsanos; A Demou; E V Tsianos
Journal:  Histol Histopathol       Date:  2003-01       Impact factor: 2.303

5.  MALDI-TOF mass spectrometry-based SNP genotyping.

Authors:  Niels Storm; Brigitte Darnhofer-Patel; Dirk van den Boom; Charles P Rodi
Journal:  Methods Mol Biol       Date:  2003

Review 6.  The use of MassARRAY technology for high throughput genotyping.

Authors:  Christian Jurinke; Dirk van den Boom; Charles R Cantor; Hubert Köster
Journal:  Adv Biochem Eng Biotechnol       Date:  2002       Impact factor: 2.635

7.  Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays.

Authors:  Thomas P Dooley; Ernest V Curto; Shanker P Reddy; Richard L Davis; Glenna W Lambert; Teresa W Wilborn; Charles O Elson
Journal:  Inflamm Bowel Dis       Date:  2004-01       Impact factor: 5.325

8.  Human metallothionein genes are clustered on chromosome 16.

Authors:  M Karin; R L Eddy; W M Henry; L L Haley; M G Byers; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.

Authors:  Laurens Kruidenier; Ineke Kuiper; Wim Van Duijn; Marij A C Mieremet-Ooms; Ruud A van Hogezand; Cornelis B H W Lamers; Hein W Verspaget
Journal:  J Pathol       Date:  2003-09       Impact factor: 7.996

Review 10.  Evidence for a potential role of metallothioneins in inflammatory bowel diseases.

Authors:  Anouk Waeytens; Martine De Vos; Debby Laukens
Journal:  Mediators Inflamm       Date:  2009-08-26       Impact factor: 4.711

View more
  2 in total

1.  Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts.

Authors:  Nishi Karunasinghe; Stefan Ambs; Alice Wang; Wei Tang; Shuotun Zhu; Tiffany H Dorsey; Megan Goudie; Jonathan G Masters; Lynnette R Ferguson
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

Review 2.  Metallothioneins in Inflammatory Bowel Diseases: Importance in Pathogenesis and Potential Therapy Target.

Authors:  Anna Socha-Banasiak; Patrycja Sputa-Grzegrzółka; Jędrzej Grzegrzółka; Krzysztof Pacześ; Piotr Dzięgiel; Beata Sordyl; Hanna Romanowicz; Elżbieta Czkwianianc
Journal:  Can J Gastroenterol Hepatol       Date:  2021-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.